Filip Borgions
Chief Tech/Sci/R&D Officer bij ARGENX SE
Profiel
Filip Borgions is currently the Global Head-Technical Operations at argenx SE since 2015.
Previously, he worked as a Principal at Thrombogenics, Inc. Dr. Borgions has an undergraduate and doctorate degree from Katholieke Universiteit Leuven.
Actieve functies van Filip Borgions
Bedrijven | Functie | Begin |
---|---|---|
ARGENX SE | Chief Tech/Sci/R&D Officer | 01-01-2015 |
Eerdere bekende functies van Filip Borgions
Bedrijven | Functie | Einde |
---|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Corporate Officer/Principal | - |
Opleiding van Filip Borgions
Katholieke Universiteit Leuven | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ARGENX SE | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Commercial Services |